BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22046311)

  • 21. Immunoregulation in murine malaria. Susceptibility of inbred mice to infection with Plasmodium yoelii depends on the dynamic interplay of host and parasite genes.
    Sayles PC; Wassom DL
    J Immunol; 1988 Jul; 141(1):241-8. PubMed ID: 3379305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transgenic mice expressing human fetal globin are protected from malaria by a novel mechanism.
    Shear HL; Grinberg L; Gilman J; Fabry ME; Stamatoyannopoulos G; Goldberg DE; Nagel RL
    Blood; 1998 Oct; 92(7):2520-6. PubMed ID: 9746793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective immunity against Plasmodium yoelii malaria induced by immunization with particulate blood-stage antigens.
    Burns JM; Dunn PD; Russo DM
    Infect Immun; 1997 Aug; 65(8):3138-45. PubMed ID: 9234766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization of mice with live-attenuated late liver stage-arresting Plasmodium yoelii parasites generates protective antibody responses to preerythrocytic stages of malaria.
    Keitany GJ; Sack B; Smithers H; Chen L; Jang IK; Sebastian L; Gupta M; Sather DN; Vignali M; Vaughan AM; Kappe SH; Wang R
    Infect Immun; 2014 Dec; 82(12):5143-53. PubMed ID: 25267837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the protective efficacy of yeast-derived and Escherichia coli-derived recombinant merozoite surface protein 4/5 against lethal challenge by Plasmodium yoelii.
    Kedzierski L; Black CG; Stowers AW; Goschnick MW; Kaslow DC; Coppel RL
    Vaccine; 2001 Sep; 19(32):4661-8. PubMed ID: 11535314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immune characteristics of
    Wang Y; Yao X; Tang MY; Liu L; Song SH; Tao ZY; Xia H; Chang XL; Fang Q
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2020 Nov; 32(6):569-576. PubMed ID: 33325190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective immunity to malaria: studies with cloned lines of rodent malaria in CBA/Ca mice. IV. The specificity of mechanisms resulting in crisis and resolution of the primary acute phase parasitaemia of Plasmodium chabaudi chabaudi and P. yoelii yoelii.
    Jarra W; Brown KN
    Parasite Immunol; 1989 Jan; 11(1):1-13. PubMed ID: 2648258
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of CD8+ T cells in protective immunity against murine blood-stage infection with Plasmodium yoelii 17XL strain.
    Imai T; Shen J; Chou B; Duan X; Tu L; Tetsutani K; Moriya C; Ishida H; Hamano S; Shimokawa C; Hisaeda H; Himeno K
    Eur J Immunol; 2010 Apr; 40(4):1053-61. PubMed ID: 20101613
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rhop-3 protein conservation among Plasmodium species and induced protection against lethal P. yoelii and P. berghei challenge.
    Wang T; Fujioka H; Drazba JA; Sam-Yellowe TY
    Parasitol Res; 2006 Aug; 99(3):238-52. PubMed ID: 16541261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intradermal immunization of mice with radiation-attenuated sporozoites of Plasmodium yoelii induces effective protective immunity.
    Voza T; Kebaier C; Vanderberg JP
    Malar J; 2010 Dec; 9():362. PubMed ID: 21159170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimalarial antibodies of the immunoglobulin G2a isotype modulate parasitemias in mice infected with Plasmodium yoelii.
    White WI; Evans CB; Taylor DW
    Infect Immun; 1991 Oct; 59(10):3547-54. PubMed ID: 1894361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunization with parasite-derived apical membrane antigen 1 or passive immunization with a specific monoclonal antibody protects BALB/c mice against lethal Plasmodium yoelii yoelii YM blood-stage infection.
    Narum DL; Ogun SA; Thomas AW; Holder AA
    Infect Immun; 2000 May; 68(5):2899-906. PubMed ID: 10768987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single injection of 19 kda carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 (PyMSP1(19)) formulated with Montanide ISA and CpG ODN induces protective immune response in mice.
    Hirunpetcharat C; Mahakunkijcharoen Y; Jeamwattanalert P; Kittigul L; Mahannop P; Pichyangkul S
    Asian Pac J Allergy Immunol; 2011 Sep; 29(3):252-9. PubMed ID: 22053595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The generation and evaluation of two panels of epitope-matched mouse IgG1, IgG2a, IgG2b and IgG3 antibodies specific for Plasmodium falciparum and Plasmodium yoelii merozoite surface protein 1-19 (MSP1(19)).
    Adame-Gallegos JR; Shi J; McIntosh RS; Pleass RJ
    Exp Parasitol; 2012 Apr; 130(4):384-93. PubMed ID: 22343045
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of lethal Plasmodium yoelii malaria following protective immunization requires antibody-, IL-4-, and IFN-gamma-dependent responses induced by vaccination and/or challenge infection.
    Petritus PM; Burns JM
    J Immunol; 2008 Jan; 180(1):444-53. PubMed ID: 18097046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Linkage of exogenous T-cell epitopes to the 19-kilodalton region of Plasmodium yoelii merozoite surface protein 1 (MSP1(19)) can enhance protective immunity against malaria and modulate the immunoglobulin subclass response to MSP1(19).
    Ahlborg N; Ling IT; Holder AA; Riley EM
    Infect Immun; 2000 Apr; 68(4):2102-9. PubMed ID: 10722607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice.
    Sanchez GI; Sedegah M; Rogers WO; Jones TR; Sacci J; Witney A; Carucci DJ; Kumar N; Hoffman SL
    Infect Immun; 2001 Jun; 69(6):3897-905. PubMed ID: 11349057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new malaria antigen produces partial protection against Plasmodium yoelii challenge.
    Zhang Y; Qi Y; Li J; Liu S; Hong L; Lin T; Long C; Su XZ
    Parasitol Res; 2012 Apr; 110(4):1337-45. PubMed ID: 21915626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Artesunate versus chloroquine infection-treatment-vaccination defines stage-specific immune responses associated with prolonged sterile protection against both pre-erythrocytic and erythrocytic Plasmodium yoelii infection.
    Peng X; Keitany GJ; Vignali M; Chen L; Gibson C; Choi K; Huang F; Wang R
    J Immunol; 2014 Aug; 193(3):1268-77. PubMed ID: 24958899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mice immunised with synthetic peptide from N-terminal conserved region of merozoite surface antigen-2 of human malaria parasite Plasmodium falciparum can control infection induced by Plasmodium yoelii yoelii 265BY strain.
    Lougovskoi AA; Okoyeh NJ; Chauhan VS
    Vaccine; 1999 Dec; 18(9-10):920-30. PubMed ID: 10580206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.